BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1762085)

  • 21. Thrombin generation and secretion of platelet Factor 4 during blood clotting.
    Shuman MA; Levine SP
    J Clin Invest; 1978 Apr; 61(4):1102-6. PubMed ID: 207723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of cytotoxic drugs on platelet functions and coagulation in vitro. IV. Melphalan.
    Klener P; Kubisz P; Suranová J
    Thromb Haemost; 1977 Feb; 37(1):53-61. PubMed ID: 576517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal vascular resistance changes following thrombin-induced intravascular coagulation: role of platelet and fibrin emboli.
    Hoie J
    Acta Chir Scand; 1975; 141(3):167-72. PubMed ID: 1166740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-Dimer and Fibrin Degradation Products Impair Platelet Signaling: Plasma D-Dimer Is a Predictor and Mediator of Platelet Dysfunction During Trauma.
    Verni CC; Davila A; Sims CA; Diamond SL
    J Appl Lab Med; 2020 Nov; 5(6):1253-1264. PubMed ID: 32674119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Various fibrinolytic and coagulation characteristics of the blood plasma after contact with N-amyl alcohol].
    Lussa A; Tymińska-Brzósko R
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1979; 24():91-104. PubMed ID: 161647
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of basic proteins on the haemostatic system of the dog.
    Worowski K; Głowiński S; Skrzydlewski Z
    Haematologia (Budap); 1978-1979; 12(1-4):165-8. PubMed ID: 575340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New method of studying the release of fibrinolysis activators in tissue cultures].
    Pandolfi M; Astedt B
    Biull Eksp Biol Med; 1977 Aug; 84(8):250-3. PubMed ID: 907833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating thrombin-loaded fibrin in whole blood clot microfluidic assay via fluorogenic peptide.
    Crossen J; Shankar KN; Diamond SL
    Biophys J; 2023 Feb; 122(4):697-712. PubMed ID: 36635963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinolysis of soluble and polymerized des-AA/des-AABB fibrin compared to fibrinogenolysis in buffer and in fibrinogen-boosted serum. Evidence that plasminogen activators are responsible for preferential degradation of polymerized fibrin.
    Brosstad F
    Thromb Res; 1979; 15(3-4):497-504. PubMed ID: 158847
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombocytin, a serine protease from Bothrops atrox venom. 2. Interaction with platelets and plasma-clotting factors.
    Niewiarowski S; Kirby EP; Brudzynski TM; Stocker K
    Biochemistry; 1979 Aug; 18(16):3570-7. PubMed ID: 476069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the interrelationship of prostaglandin endoperoxide G2 and cyclic nucleotides in platelet function.
    Claesson HE; Malmsten C
    Eur J Biochem; 1977 Jun; 76(1):277-84. PubMed ID: 195812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro studies and model calculations on the kinetics of fibrinolysis with streptokinase].
    Senf L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):899-907. PubMed ID: 94884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glomerular fibrinolytic activity after thrombin perfusion in the rat.
    Sraer JD; Delarue F; Dard S; De Seigneux R; Morel-Maroger L; Kanfer A
    Lab Invest; 1975 Apr; 32(4):515-7. PubMed ID: 123973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial injury induced by thrombin or thrombi.
    Lough J; Moore S
    Lab Invest; 1975 Aug; 33(2):130-5. PubMed ID: 1099336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The formation of a fibrinogen-activator complex by the action of streptokinase.
    Chesterman CN; Cederholm-Williams SA; Allington MJ; Sharp AA
    Thromb Res; 1977 Mar; 10(3):421-30. PubMed ID: 854878
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-thrombotic Effects Mediated by a Novel Dual-Target Peptide Inhibiting Both Platelet Aggregation and Thrombin Activity without Causing Bleeding.
    Yu J; Wang T; Zhang X; Chen Q; Hu Y; Liang Q; Shi Y; Wang Y; Zhang Y; Yu M; Zhao B
    Thromb Haemost; 2024 Feb; 124(2):108-121. PubMed ID: 37657484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alterations of plasma plasminogen and fibrinogen, serum fibrin degradation products and degree of ADP induced platelet aggregation in acute myocardial infarction (author's transl)].
    Zhonghua Xin Xue Guan Bing Za Zhi; 1979; 7(1):49-52. PubMed ID: 550980
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro inhibition of endotoxin induced platelet aggregation with hydrocortisone sodium succinate (Solu-Cortef).
    Nelson WR; Taylor GA
    Scand J Haematol; 1975 Aug; 15(1):35-44. PubMed ID: 1101367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings: Effect of ADP and thrombin on fibrin retraction induced by human platelets and fibroblasts.
    Niewiarowski S; Stewart GJ; Goldstein S
    Thromb Diath Haemorrh; 1975 Sep; 34(1):316-7. PubMed ID: 1188720
    [No Abstract]   [Full Text] [Related]  

  • 40. Fibrinogen-fibrin related antigen pattern in human blood. Incomplete lysis of whole blood clots by urokinase.
    Jacobsen CD; Fry GL; Wu KK; Southers NJ
    Thromb Res; 1975 Apr; 6(4):327-36. PubMed ID: 1079637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.